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Abstract The PACSIN-related proteins are cytoplasmic adap- 
ter proteins with a common arrangement of domains and 
conserved regions. Here we report the cloning, sequencing, and 
expression of PACSIN 2, a novel member of the PACSIN 
protein family and accordingly rename the original PACSIN to 
PACSIN 1. The sequences of the murine and human cDNAs 
reveal an open reading frame encoding a putative protein of 486 
residues. Despite its high sequence similarity to PACSIN 1, 
PACSIN 2 is encoded by distinct transcripts in human and 
mouse, in particular displaying a ubiquitous expression pattern. 
Immunofluorescence microscopy of PACSIN 2-transfected 
NIH3T3 fibroblasts reveal a broad, vesicle-like cytoplasmic 
staining. In contrast o FAP52, another PACSIN-related protein 
derived from chicken brain, PACSIN 2 could not be detected at 
focal contacts. Taken together, these findings suggest that 
PACSIN 2 is a novel PACSIN isoform with similar domain and 
motif arrangement, but an unrestricted expression pattern, which 
may participate in the organization of the actin cytoskeleton and 
the regulation of vesicular traffic. 
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1. Introduction 
We previously identified PACSIN 1 as a member of a novel 
class of cytoplasmic adapter proteins [1], which share charac- 
teristic structural features uch as a well conserved C-terminal 
protein binding SH3 domain and a CDC15-NT domain which 
includes an N-terminal RAEYL  motif  and a central coiled- 
coil region. The latter domain represents an uncharacterized 
profile (PS50133) in the PROSITE database with the RAEYL  
motif  being the highly conserved region at its N-terminus. 
PACSIN 1 exhibits a highly restricted expression pattern 
and is detected predominantly in terminally differentiated neu- 
ral tissues, with maximal expression in the adult. During 
mouse brain regeneration the expression of PACSIN 1 drops 
dramatically. Recently Qualmann et al. [2] reported the iden- 
tification of the rat homolog of PACSIN 1, syndapin 1, based 
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on its ability to bind to the proline-rich domain (PRD) of 
dynamin. Syndapin 1 was found to be enriched in synapses 
and to bind to three major nerve terminal proteins implicated 
in the trafficking of synaptic vesicles, synaptojanin 1, dynamin 
1 and synapsin 1, via its C-terminal SH3 domain. The same 
protein binding domain of syndapin 1 interacts with N- 
WASP, a multidomain homolog of the Wiskott-Aldrich syn- 
drome protein (WASP) also found in nerve terminals. This 
was shown to associate with actin filaments and thereby reg- 
ulates the dynamics of the actin cytoskeleton. Several other 
PACSIN 1-related sequences have been described. One, 
FAP52, recovered from chicken brain, is a phosphoprotein 
with 70% identity to PACSIN 1, which is localized in focal 
adhesion contacts [3]. A second encodes an as yet incom- 
pletely characterized Echinococcus antigen, EM13, with 34% 
sequence identity to PACSIN 1 [4]. The third predicts the less 
homologous PSTPIP which is thought to be involved in the 
control of cleavage furrow formation during cytokinesis and 
appears to be the mammalian homolog of the Schizosaccha- 
romyces pombe phosphoprotein CDCI5p [5,6]. PSTPIP has 
recently been shown to bind to WASP in an SH3-mediated 
and tyrosine phosphorylation-dependent manner [7]. All fam- 
ily members appear to be involved in signaling pathways as- 
sociated with the organization of cytoskeletal structures. 
Assuming the existence of more members of this novel fam- 
ily of cytoplasmic phosphoproteins, we attempted to identify 
further gene products with a similar modular structure by 
sequence comparison and search of EST databases. Here we 
report the deduced primary structure of murine and human 
PACSIN 2, which are highly homologous to PACSIN 1 and 
FAP52, differing mainly by the inclusion of a 41 amino acids 
long PACSIN 2-specific region. 
2. Materials and methods 
2.1. Clones and libraries 
A murine fetal EST clone, IMAGE Consortium clone 1D no. 
373221, representing a fragment of PACSIN 2, was obtained from 
the UK HGMP Resource Center. Two human EST clones derived 
from adult retina, clone ID no. 220502 (IMAGp998115437), and in- 
fant brain, clone ID no. 50687 (IMAGp998HI7283), were obtained 
from the Resource Center of the German Human Genome Project 
(RZPD). Four filters with dotted cDNA derived from a 9 days post- 
coitum murine embryo cDNA library (RZPD no. 559) and corre- 
sponding positive clones were obtained from the RZPD. 
2.2. Isolation of clones and DNA analysis 
Filter hybridization of a murine cDNA library (see Section 2.1) was 
pertbrmed in 50% formamide, 5×Denhardt's solution (50×Den- 
hardt's solution is 1% BSA, 1% Ficoll 400, and 1% polyvinylpyrroli- 
done), 5×SSPE (1 XSSPE is 0.15 M NaC1, 10 mM sodium phosphate 
(pH 7.6), and 1 mM EDTA), 1.5% SDS (sodium dodecyl sulfate), and 
300 gg/ml salmon sperm DNA with a 520 bp probe specific for mouse 
PACSIN 2. The cDNA fragment was derived from the EST clone 
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373221 by EcoRI/XmnI digestion and radiolabeled by random pri- 
ming (TaKaRa). The filter were finally washed with 0.1XSSC (1 x 
SSC is 0.15 M NaC1, 15 mM sodium citrate, pH 7.5) and 0.1% SDS at 
65°C for 20 min, and subjected to autoradiography. Positive clones 
from the library as well as EST clones were sequenced in both direc- 
tions with universal and internal primers using the ABI Prism Big Dye 
Terminator Cycle Sequencing Ready Reaction Kit, and products re- 
solved on an ABI Prism 377 Automated Sequencer (Perkin Elmer/ 
Applied Biosystems). DNA and protein sequence analysis were per- 
formed using the GCG software package (University of Wisconsin, 
Madison, WI, USA) and multiple gene databases were searched using 
the BLAST programs [8]. 
2.3. Northern blot analysis" 
Poly(A) + RNA was isolated from freshly prepared murine tissues 
by guanidinium thiocyanate lysis using the Oligotex mRNA Kit (Qia- 
gen). 5 gg poly(A) + RNA per tissue was electrophoresed on a 1% 
agarose gel containing formaldehyde and transferred onto Hybond 
XL membrane (Amersham) by capillary transfer. Hybridization was 
performed in the same formamide mix as used for cDNA library filter 
hybridization using the radiolabeled (TaKaRa) 520 bp probe specific 
for mouse PACSIN 2 (see Section 2.2). The filter was washed strin- 
gently with 0.1×SSC and 0.1% SDS at 65°C for 10 min, and sub- 
jected to autoradiography. Prior ethidium bromide staining of the gel 
and hybridization with GAPDH cDNA were used to control equal 
loading and checking RNA integrity. 
2.4. lmmunofluorescenee 
The complete open reading frame of murine PACSIN 2 was cloned 
into the enkaryotic expression vector pMyc-CMV (Clontech) in order 
to express myc-tagged PACSIN 2. NIH3T3 fibroblasts were grown to 
70% confluence and transfected with 2 gg DNA and 6 p_l FuGENE 6 
(Roche) per well of a 6-well dish. After 24 h, cells were plated on 
circular 12 mm glass coverslips in 24 well dishes. 48 h after trans- 
fection cells were fixed in 2% paraformaldehyde in PBS for 10 min 
and permeabilized by incubation in 0.2% Triton X-t00 in PBS for 
1 rain. All antibody incubations and washing steps were performed 
in TBS containing 0.1% Tween 20. Myc-tagged mouse PACSIN 2 was 
detected using a polyclonal rabbit serum against c-myc (A-14, Santa 
Cruz, dilution 1:1000) in combination with a Cy2-conjugated anti- 
rabbit immunoglobulin serum (Jackson ImmunoResearch Laborato- 
ries, dilution 1:400). F-actin was stained using TRITC-conjugated 
phalloidin (Sigma, dilution 1:80). Microtubules were detected with a 
mouse anti-a-tubulin monoclonal antibody (N356, Amersham, dilu- 
tion 1:50), the focal adhesion proteins with a monoclonal nti-paxillin 
antibody (clone 349, Transduction Laboratories, dilution 1:100), and 
the monoclonal anti-vinculin antibody (clone VIIFS, gift from Dr. M. 
Glukhova, Institute Curie, Paris, France, dilution 1:2). For visualiza- 
tion of microtubules, paxillin, and vinculin, a Cy3-conjugated goat 
anti-mouse immunoglobulin serum (Jackson ImmunoResearch Labo- 
ratories, dilution 1:200) was used. Confocal laser scanning micro- 
scopy (Leica) was used to scan sections 1(~32 times. Processing of 
the resulting pictures was performed using Adobe Photoshop 3.0. 
3. Results 
3.1. Isolation of  PACS IN  2 cDNA 
A search of EST databases yielded several murine and hu- 
man EST clones with sequence identity to PACSIN 1 and 
FAP52 of about 73% and 78%, respectively. Using a fragment 
of EST clone 373221 representing the 5'-region of murine 
PACSIN 2 as a probe, we obtained two clones on screening 
a mouse embryo cDNA library. Each contained the entire 
coding region (position 251-1711) and comprised the com- 
plete cDNA of mPACSIN 2 with a length of 3217 bp (Fig. 
1A). The first in-frame ATG is located 251 nt from the 5'-end 
and fulfills Kozak's criteria for a translation initiation site 
showing conservation of six of 10 bases in the consensus [9]. 
This putative initiator was preceded by two in-frame stop 
codons located 173 and 42 nu61eotides upstream (Fig. 1A). 
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For the complete human PACSIN 2 transcript of 3255 bp the 
sequences of the EST clones 220502 and 50687 were com- 
bined. The putative translation initiation site is located at 
nucleotide positions 209-211 and also preceded by two in- 
frame stop codons (nucleotide positions 59 and 173, respec- 
tively). 
The predicted protein products encoded by the open read- 
ing frames are both 486 residues long (Fig. 1) with a calcu- 
lated molecular weight of 55 833 (mouse) and 5 905 Da (hu- 
man), respectively. The human and murine PACSIN 2 
sequences how significant homology at both the cDNA and 
protein levels with 79.8% and 93.6% identity, respectively 
(Fig. 2A). Furthermore, the murine PACSIN 2 protein is 
89% identical to chicken FAP52 and 70% to murine PACSIN 
1, but compared to these PACSIN 2 contains a unique 41 
amino acid insertion (Fig. 2B). This insertion is part of a 
region which individually characterizes each PACSIN-related 
protein and contains an additional third NPF  motif  besides 
the two NPF motifs also found in PACSIN 1 and FAP52. 
The general domain organization of PACSIN 2 is consistent 
with the arrangement found in other related proteins (Fig. 
2B). A CDC15 N-terminal domain is localized between resi- 
dues 47 and 245, and the C-terminus is characterized by a well 
conserved SH3 domain. 
3.2. Expression of  PACS IN  2 
In contrast o the restricted neural expression of PACSIN 1 
[1], Northern blot analysis revealed a more ubiquitous distri- 
bution of PACSIN 2 (Fig. 3). The specific transcript of 3.5 kb 
was detected in all tissues tested with highest levels in brain, 
heart, skeletal muscle, and ovaries. A search of the EST data- 
base yielded a high number of human and murine clones that 
could be identified as fragments of PACSIN 2 cDNA. These 
EST clones originate from a large number of different issues, 
a finding which further supports the ubiquitous expression. 
Additionally PACSIN 2 was found in several tumors and 
pathologically altered tissues (data not shown). Furthermore, 
PACSIN 2 is expressed in adult tissues as well as in tissues 
and cells derived from very early stages of development (e.g. 
EST clone J0701E04, accession number AU014698, derived 
from a murine two-cell embryo). 
3.3. Intracellular localization of  PACS IN  2 
The intracellular localization was studied employing 
NIH3T3 fibroblasts transfected with myc-tagged PACSIN 2 
(Fig. 4). In contrast o FAP52, PACSIN 2 shows a vesicle-like 
distribution throughout the cell. The costaining of cytoskeletal 
structures with phalloidin (Fig. 4A-C) and anti-~-tubulin 
(Fig. 4D F), showing the actin filament and microtubule net- 
works, respectively, revealed that PACSIN 2 distribution 
seems to overlap at least partially with both cytoskeletal net- 
works. As a negative control NIH3T3 cells transfected with a 
myc-tagged vector without insert were processed for indirect 
immunofluorescence, but no staining was detected using an 
anti-myc antibody (data not shown). 
Since PACSIN 2 is highly similar to the focal adhesion 
protein FAP52, which localizes together with paxillin and 
vinculin in focal contacts of chicken embryo fibroblasts 
[3], we used antibodies against both proteins, but failed to 
localize PACSIN 2 in focal contact sites of NIH3T3 cells 
(Fig. 4GL) .  
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CCGGGT CGACCCACGCGT CCGCGGAAGGAGGCAGGTGCT CAGCAG 45 
ATCT GCAAAGTTAGGCTGCTGCAGCCAGCGGCTGACAGAG~AACG 90 
T GAGT G T G C T T TA-AG GAAGAC C T TC T G~AG T C GAAT T T C T G CAC 135 
TTTGTTTTTTCTTGTTCGCGTGATTGCCAGCAGTCTCACCTTGTC 180 
TGTCTGCAGGTTTTACACAT CTGACCCCT GAAC TGGAGT G TC T G C 225 
TGCCACCCCCTCGTCCTC TGCAGA~TGTCTGTCACCTACGATGA 270 
1 M S V T Y D D 
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8 S V G V E V S S D S F W E V G 
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C T T CAAG GAGACC/ iAAGAAGCAGAGGAT GG C T T T CGGAAG G C C CA 675 
12 8 ~{%,.~,{ 
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2 0 3 g 5 ! ~ . ~  
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263 Y K T I Y R E L E Q $ I K A A 
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278 D A V E D L R W F R A N H G P 
AGGCATGGCTATGAACTGGC CACAGTTTGAGGAGTGGTCT GCAGA 1170 
293 G M A M N W P Q F E E W S A D 
TCT GAATC GAACTCTCAGCCGGAGAGAGAAGAAGAAGGCTGTTGA 1215 
3O8 L N R T L S R R E K K K A V D 
CGGTGTCACCCTAACAGGGATC~LACCAGACAGGTGACCAGTCT GG 1260 
323 G V T L T G I N Q T G D Q S G 
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353 Q S T Q L Q S S Y N P F E D E 
GGACGACACGGGCAGCAGCATCAGTGAGAAGGAGGACAT TAAGGC 1395 
368 D D T G S S I S E K E D I K A 
C /b~T G T CAG CAG C TAT  GAGAAGAC T CAGAC T TAC C C CAC T GA 1440 
383 K N V S S Y E K T Q T Y P T D 
CTGGT C TGATGAT GAGTC TAAC~_ACCCT T CT C CTCCAC GGATGC 1485 
398 W S D D E S N N P F S S T D A 
CAAC GGGGATTCGAACCCATTTGATGAGGACAC GACC T CAGGAAC 1530 
413 N G D S N P F D E D T T S G T 
AGAAGT GCGAGTTCGGGC CCTCTATGACTATGAGGGGCAGGAACA 1575 
428 E V R V R A L Y D Y E G Q E H 
TGAT GAGCT GAG C T T C~.AGGC T G G G GAT GAAC T GAC CAAGATAGA 1620 
443 D E L S F K A G D E L T K I E 
GGAT GAAGAT GAACAGGG T T GGT GCAAG GGAC GT T TAGACAGC GG 1665 
458 D E D E Q G W C K G R L D S G 
CCAGGTTGGCCTATACCCAGCCA/~CTATGTCGAGGCTATCCAGTG 1710 
4 7 3 Q V G L Y P A N Y V E A I Q *  
ACAGCCCATGGGCAGGCTGGCGGAGAGACGGA~TGGGCAGTTCA 1755 
GGAGCTCCGTTAGCCTTGGCCTGGGCAGTGACACCTCTAGTGCCC 1800 
CCAGCAGCCATGTAGGCATCCACTCCACCTGCAAAAGACGATGGC 1845 
TCTGTTGTTCTTGGCTTCCTGGTGTGCTTTGAAGGCAGATGAGCT 1890 
GGTGATTTCATTGGGCACTTGGCCCTTTTCCAAGCACATCTGGGC 1935 
AGATATAGACACAGG~AGATAGGGTCCAACAGCGAGAGCCAGGCC 1980 
CCTCCCCACCCCCACCAGCTCTCTCTATCATGGATCTGCACCTTC 2025 
TCGCCCTTGTCTCTCCTGAGTCATGACGGGTCATACTGATTCTTG 2070 
TTCCACTGATGATTTTCTCTGATGAGGTCCTATCTGCAAGGTCAA 2115 
TGAGCAGACTTACATGCCATCTTCTGAGTA~GAGTTTGAGGTTT 2160 
TAATTTA~GGCA.~TGTACAGCTATACTTTTTTATATGCTCTTCC 2205 
AGTCAGTTAAATTATGGCCTACACTGATCTGAGATGTTCTCCACG 2250 
TGAGCTGTCTTCATTTCTCTGTGCTATGTCCAGATGTGGGGTTGC 2295 
TGCAGCCGGGGTTCTATGGCAAGTGCCAGTTGCAGGGCTAACCTT 2340 
GTGCAACGTTCCCCAACACTTCCACATACAGA~TTATTTTCACT 2385 
CTATCCCTGCTTCAGTTTTTGCAGATTAACAGTTCTATTAGTGAT 2430 
TTGGAAAGTTAACAGTAAGAAGACTAACTTTTCA~CAGTTGCA 2475 
TCTGTAGATTAAGATGCTTTACATTAGACCGTTGTGTCTCGATGT 2520 
ATATCTGTATATATTATTTGATAATCAGA/~TCTATAGAGTTCA 2565 
CCCACTGTTGAATGAGAGCTGGTGGCTTCTGACAGCAGATCTGGT 2610 
CA-ACTGCTTGATGCCCATGCATTGA_AGCACAGGCACGGCTGGTTA 2655 
ACGGTGCCCACCCAGTTAGGATGTGGCTCTGGCCTCTGAATGGAA 2700 
CTGCTGGGAAGAACTGAATTCTCATTGGCCCTGGGCTCCAGCTCA 2745 
TGACGAGCACTGGAAAGCTCCTAGGAACTTGGTTAGTAATCGTTA 2790 
GACTTCACAGTCCCTGTGTTCACTCACTGGAGAGCTAGAGGGAGG 2835 
GGTTGAACACCCTCCACCACACACACACACACACACACACACACA 2880 
CACACAAGTTCCTCCAGTTGCCCTTGTCCTCAGGTGCAGTGGGAC 2925 
TGTTGTGAGCCCCAGGGACGGGCACAAAGAGGACTTTTATTTTGT 2970 
TAGCTCGGACAGTGCAGTGGTGCACATCAGCAACTTGTATTTCTT 3015 
CGGTGTTTGGCACGAGCACTGTCTCGCTGTGGCTGTGTGTCATGA 3060 
GAACTTACCAGCAGAAATCCTTGTTCCTAAGCTACAGAATGACCA 3105 
2hAAGCTGTCAAGTCCTT~ATGTTTAGAAACTCCTTA/~TGTATA 3150 
GTATTTTAGAACAACAACAACA~CTCAATAAACAGTTGATCTT 3195 
GTGTGTTTGACAGTCCCTTA/~T 3217 
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AGTGCAGCTGGAGGGATCTGAGCGCAGGAAGACGCAG~LACAACAG 1890 
AAATAGCCGCCCCTCCCCGCCCACTGTGCCTGTTGGCCTATCATA 1935 
GATCTCTATGTTCTTGACTTTGTCTCTCCTTTCCGAGTCAATGGT 1990 
GGGTTACACTGATCTTGTTCCACTGATTACTCTCTCTGACGAGTC 2025 
CATCACCTGCAACTTAAATGAACAAGCTTACATCCCATTTTGAGT 2070 
GAAGATTTTGAGGTTTTTAATTTA~GGCTGTGTACAGTTATACT 2115 
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CATTCAGGCACACGTCTGGCTGGCCGGCTGGGTCTCCTCCCGGGC 2700 
TCAGTGGGCCTGGGGCCTCTCTGACGTGGTGCCTGCTGGAGGGAG 2745 
GCTCGTCGTCACCAGCTGACTGCTGGTCCGGCTTCTGACCGGCCT 2790 
TTGTCCTGGCTCCGTAGCAGAACACTGTA~GTGCCCGCGTCTT 2835 
TGCAGTAGTTGCAGATTTCAGTCGTCGTGTTACTTGTGCACAAAC 2880 
AG2h~GCTGGGTCTTACCCGCAGCACGAGTGTCTCGGGCTGCCCGG 2925 
AGTCGCCCGGGAGCAGGTGCTGCAGCCAGAGTTACGCGGGGGCCA 2970 
CGCGGGCCGGCGGGGGTGGGGGGAACGTGGGGG~-ACCTGTGTTTC 3015 
ACGTGACTCAGCAGTGCCCGCCGCCGTCACCAGCTATGCATTCAC 3060 
TCCGTTTCCAGTGAGCAGATGTCTTGCTTGGAAAGTGGACCTGTG 3105 
TCTGTGTCTGTCCTGAGAACTTACCAGCAG~ATCCTCATTTCTG 3150 
TGCTACGGATTTACCA~TTGTCAAGTCTTTTTCAGTTTAACA 3195 
GTTCCTTTACATGTGTAGTATTTGAGGA~TCAATAAACAG 3240 
TTGATCTCGTGCATA 3255 
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Fig. 1. Annotated nucleotide sequences of full-length mouse (A) and human (B) cDNAs encoding PACSIN 2. The numbers on the left and 
right sides of the sequences indicate amino acid residues and nucleotide positions, respectively. Within the nucleotide sequence the in-frame 
stop codons are marked by asterisks, and the putative poly(A) signals (AAUAAA) are indicated by bold letters at the end of the 3'-UTR (un- 
translated regions). Within the protein sequence the CDC15 NT domains are highlighted by gray shading, the EH domain binding NPF motifs 
by bold letters, and C-terminal SH3 domains are underlined. 
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4. Discussion 
It was recently demonstrated that syndapin l, the rat ho- 
molog of murine PACSIN 1, binds to dynamin 1, synaptoja- 
nin l, synapsin 1 and N-WASP via its C-terminal SH3 do- 
main [2]. We now report the identification of a novel isoform, 
PACSIN 2, which in contrast to PACSIN 1 appears to be 
ubiquitously expressed. Despite its high similarity to PACSIN 
1 (70% identity), and therefore comparable arrangement of  
motifs and domains, PACSIN 2 contains an additional pep- 
tide sequence including a third NPF motif. The presence of an 
SH3 domain, three NPF motifs, and a central coiled-coil re- 
gion located within the CDC15-NT domain suggests a func- 
tion as an adapter protein. This interpretation is supported by 
the fact that syndapin 1 binds to four different proteins via its 
SH3 domain [2]. Some of these proteins have been shown to 
participate in endocytic processes [10-12]. Additionally, sev- 
eral proteins that are involved in vesicle formation during 
endocytosis contain either EH domains or their corresponding 
NPF binding motifs (reviewed in [13]). Within PACSIN 2 
three of these motifs are present between the CDC15-NT 
domain and the C-terminal SH3 domain, all of which are 
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Fig. 2. Comparison of the murine and human PACSIN 2 deduced amino acid sequences with those of related proteins. A: Sequence alignments 
of both PACSIN 2 proteins (mPACSIN2 and hPACSIN2) with murine PACSIN 1 (mPACSIN1) and chicken FAP52 (gFAP52). Identical ami- 
no acids are shown in white against black, and conservatively substituted ones are shaded. Gaps in the sequences, needed to optimize the align- 
ment, are represented by dots. B: Comparison of the ]nodular structure of PACSIN-related proteins. All proteins contain a CDC15 NT do- 
main, including a coiled-coil region and a C-terminal SH3 domain, indicated as black modules. Additionally members of the PACSIN protein 
family contain up to three conserved regions, specific for the PACSIN family, which are shaded gray. The more distantly related PSTPIP in- 
stead contains regions specific for the PSTPIP family at these positions. Individually distinct modules are indicated by different stripe patterns. 
The overall amino acid identity and similarity (including conservatively substituted residues) of the individual proteins to murine PACSIN 2 is 
given at the right. 
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Fig. 2 (continued). 
potentially able to bind to proteins containing EH domains 
[14]. Also the aspartic acid residue adjacent o the first NPF  
motif  at residue 366 exactly matches the consensus equence 
NPFxD characterizing a new class of endocytosis ignals in 
Saccharomyces cerevisiae [15]. While expression of synapsin 1 
3.5- PACSIN 2 
1.3 GAPDH 
EtBr 
stain 
Fig. 3. Expression of mouse PACSIN 2 in adult murine tissues. 
Northern blot was performed with approximately 5 lag of poly(A) + 
RNA per lane. The filter was hybridized with a fragment of clone 
373221 containing the 5' untranslated region and parts of the open 
reading frame. Integrity of RNAs and standardization of loaded 
amounts were checked by ethidium bromide staining of the gel and 
reprobing with a GAPDH control probe. 
and synaptojanin 1 is restricted to the nervous system [16,17], 
other interaction partners of syndapin 1, e.g. N-WASP, or 
isoforms of interaction partners, e.g. dynamin 2, are also ex- 
pressed in non-neural tissues [18,19]. These may interact with 
the PACSIN 2 SH3 domain in other tissues. 
PACSIN 2 shows a high similarity to FAP52, a PACSIN 
family member with a broad tissue distribution and an intra- 
cellular localization to focal contacts [3]. Although PACSIN 2 
appears to be the mammalian homolog of FAP52, PACSIN 2 
shows no colocalization with paxillin and vinculin in NIH3T3 
fibroblasts. Also when compared to FAP52, the human and 
murine PACSIN 2 proteins contain an insertion of 41 amino 
acids, which leads to a theoretical molecular weight of 56 
kDa. Such an insertion could explain the discrepancy between 
the FAP52 63 kDa signal seen in Western blots compared to 
the calculated molecular weight of 52 kDa [3]. Although we 
have found no evidence for alternative splicing of PACSIN 2 
transcripts in Northern blots and the EST database, we can- 
--> 
Fig. 4. Immunofluorescence analysis of the localization of PACSIN 
2 in fibroblasts. Transiently transfected NIH3T3 cells expressing 
myc-tagged PACSIN 2 were fixed with 2% PFA and processed for 
indirect immunofluorescence as described in Section 2. After perme- 
abilization, PACSIN 2 distribution was determined using an anti- 
myc antibody (A, B, D, E, G, H, J, and K). Cytoskeletal networks 
were visualized using TRITC-labelled phalloidin for actin (B and C) 
and an anti-c~-tubulin monoclonal antibody for microtubules (E and 
F). Focal adhesions were stained by using antibodies against paxillin 
(H and I) and vinculin (K and L). 
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not rule out that FAP52 might represent another splice var- 
iant occurring in chicken. 
Immunofluorescence microscopy for PACSIN 2 in NIH3T3 
fibroblasts revealed a vesicle-like cytoplasmic distribution, 
that seems to partially overlap with that of microtubules 
and the actin network. Both participate on vesicular trans- 
port. 
In conclusion, we have identified PACSIN 2 as a novel 
member of the PACSIN protein family that in contrast to 
the closely related PACSIN 1, which only occurs in neural 
tissues, appears to be ubiquitously expressed. The similar ar- 
rangement of domains and motifs, together with features of 
the intracellular localization suggest a participation in endo- 
cytic processes. Although most proteins binding to syndapin 
1, the rat homolog of PACSIN 1, are localized in nerve ter- 
minals, many are also members of protein families with some 
members having a more widespread expression pattern. These 
other members may show interactions with PACSIN 2. 
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